April 12, 2022
Surf Bio Announces $16 Million Series Seed Financing
Surf Bio, Inc., a biopharmaceutical company commercializing a novel drug stabilization platform, today announced a $16 million Series Seed round…
Pharmaceuticals, Biotechnology and Life Sciences
Surf Bio, Inc., a biopharmaceutical company commercializing a novel drug stabilization platform, today announced a $16 million Series Seed round…